These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 29322567)
1. Oral delivery system enhanced the bioavailability of stilbenes: Resveratrol and pterostilbene. Peng RM; Lin GR; Ting Y; Hu JY Biofactors; 2018 Jan; 44(1):5-15. PubMed ID: 29322567 [TBL] [Abstract][Full Text] [Related]
2. Metabolism and pharmacokinetics of resveratrol and pterostilbene. Wang P; Sang S Biofactors; 2018 Jan; 44(1):16-25. PubMed ID: 29315886 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Kapetanovic IM; Muzzio M; Huang Z; Thompson TN; McCormick DL Cancer Chemother Pharmacol; 2011 Sep; 68(3):593-601. PubMed ID: 21116625 [TBL] [Abstract][Full Text] [Related]
4. Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles. Ramalingam P; Ko YT Colloids Surf B Biointerfaces; 2016 Mar; 139():52-61. PubMed ID: 26700233 [TBL] [Abstract][Full Text] [Related]
5. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity. Siu FY; Ye S; Lin H; Li S Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494 [TBL] [Abstract][Full Text] [Related]
6. Nanoemulsion for solubilization, stabilization, and in vitro release of pterostilbene for oral delivery. Zhang Y; Shang Z; Gao C; Du M; Xu S; Song H; Liu T AAPS PharmSciTech; 2014 Aug; 15(4):1000-8. PubMed ID: 24831090 [TBL] [Abstract][Full Text] [Related]
7. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability. Lin HS; Ho PC J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of pterostilbene in Sprague-Dawley rats: the impacts of aqueous solubility, fasting, dose escalation, and dosing route on bioavailability. Yeo SC; Ho PC; Lin HS Mol Nutr Food Res; 2013 Jun; 57(6):1015-25. PubMed ID: 23417986 [TBL] [Abstract][Full Text] [Related]
9. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model. Cherniakov I; Izgelov D; Domb AJ; Hoffman A Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol: nanocarrier-based delivery systems to enhance its therapeutic potential. Singh G Nanomedicine (Lond); 2020 Dec; 15(28):2801-2817. PubMed ID: 33191840 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol and other Stilbenes: Effects on Dysregulated Gene Expression in Cancers and Novel Delivery Systems. Poltronieri P; Xu B; Giovinazzo G Anticancer Agents Med Chem; 2021; 21(5):567-574. PubMed ID: 32628597 [TBL] [Abstract][Full Text] [Related]
12. In-vitro/in-vivo characterization of trans-resveratrol-loaded nanoparticulate drug delivery system for oral administration. Singh G; Pai RS J Pharm Pharmacol; 2014 Aug; 66(8):1062-76. PubMed ID: 24779896 [TBL] [Abstract][Full Text] [Related]
13. Dendrimer nanotechnology for enhanced formulation and controlled delivery of resveratrol. Chauhan AS Ann N Y Acad Sci; 2015 Aug; 1348(1):134-40. PubMed ID: 26173478 [TBL] [Abstract][Full Text] [Related]
14. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Singh G; Pai RS Drug Deliv; 2015; 22(4):522-30. PubMed ID: 24512464 [TBL] [Abstract][Full Text] [Related]
15. Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in Rats. Chang CW; Wong CY; Wu YT; Hsu MC Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):239-249. PubMed ID: 27118361 [TBL] [Abstract][Full Text] [Related]
16. A novel monolithic controlled delivery system of resveratrol for enhanced hepatoprotection: nanoformulation development, pharmacokinetics and pharmacodynamics. Singh A; Ahmad I; Ahmad S; Iqbal Z; Ahmad FJ Drug Dev Ind Pharm; 2016 Sep; 42(9):1524-36. PubMed ID: 26902951 [TBL] [Abstract][Full Text] [Related]
17. A Novel Self-Microemulsifying System for the Simultaneous Delivery and Enhanced Oral Absorption of Curcumin and Resveratrol. Jaisamut P; Wiwattanawongsa K; Wiwattanapatapee R Planta Med; 2017 Mar; 83(5):461-467. PubMed ID: 27280934 [TBL] [Abstract][Full Text] [Related]
18. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. Wang S; Su R; Nie S; Sun M; Zhang J; Wu D; Moustaid-Moussa N J Nutr Biochem; 2014 Apr; 25(4):363-76. PubMed ID: 24406273 [TBL] [Abstract][Full Text] [Related]
19. Administration of resveratrol: What formulation solutions to bioavailability limitations? Amri A; Chaumeil JC; Sfar S; Charrueau C J Control Release; 2012 Mar; 158(2):182-93. PubMed ID: 21978644 [TBL] [Abstract][Full Text] [Related]